NCT06233838View on ClinicalTrials.gov

Multi-center Clinical Study on Hemoperfusion of KHA80

NARecruitingINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

May 31, 2027

Conditions
UremiaUremic OsteodystrophyDialysis Related Complication
Interventions
DEVICE

KHA80 hemoperfusion treatment

On the basis of hemodialysis or hemodiafiltration treatment, Jianfan KHA80 hemoperfusion treatment was given, and the frequency of hemoperfusion treatment was ≥2 times/month.

Trial Locations (1)

350000

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER